1-(4-CHLOROPHENYL)-2-CYCLOPROPYLETHANONE, 95.0%, 250mg

3-(chloromethyl)-1-isopropyl-1H-pyrazole, 1g

(1-methylcyclopentyl)amine hydrochloride, 95.0%, 5g

(2S,2'S,3S,3'S)-3,3'-di-tert-Butyl-2,2'-diethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97%, 100mg

(S)-4-(tert-Butyl)-2-(2-chloro-6-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 97%, 1g

4-Bromo-3-methoxybenzenesulfonyl chloride, 95.0%, 5g

2-(Trifluoromethyl)benzenesulfonyl Chloride>98.0%(GC)1g

rEGCase I assisted by Activator II1vial

SPIRO[2.3]HEXAN-4-OL, 95%, 100mg

5-(Difluoromethyl)-1H-pyrazol-3-amine, 95.0%, 1g

1-Boc-5-Aminoindole, 95.0%, 5g

7-Bromo-2,3-dihydrobenzofuran-3-amine hydrochloride, 97%, 1g

N-Methyl 2-bromo-4-fluoroaniline, HCl, 97%, 5g